MICHELUCCI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 4.448
EU - Europa 2.855
AS - Asia 1.535
SA - Sud America 182
AF - Africa 39
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 34
Totale 9.129
Nazione #
US - Stati Uniti d'America 4.390
RU - Federazione Russa 966
IT - Italia 492
SG - Singapore 453
PL - Polonia 406
CN - Cina 350
HK - Hong Kong 276
SE - Svezia 223
IE - Irlanda 201
DE - Germania 165
VN - Vietnam 162
UA - Ucraina 141
BR - Brasile 138
KR - Corea 118
FI - Finlandia 97
FR - Francia 69
GB - Regno Unito 52
IN - India 40
CA - Canada 38
AU - Australia 36
JO - Giordania 36
AR - Argentina 21
BD - Bangladesh 17
TR - Turchia 15
JP - Giappone 11
CI - Costa d'Avorio 9
ID - Indonesia 9
IQ - Iraq 9
CH - Svizzera 8
MX - Messico 8
ZA - Sudafrica 8
NL - Olanda 7
PK - Pakistan 7
CO - Colombia 6
EC - Ecuador 6
ES - Italia 6
NG - Nigeria 5
PH - Filippine 5
RO - Romania 5
KG - Kirghizistan 4
MA - Marocco 4
SA - Arabia Saudita 4
SC - Seychelles 4
UZ - Uzbekistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
CZ - Repubblica Ceca 3
GR - Grecia 3
JM - Giamaica 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
GT - Guatemala 2
OM - Oman 2
PE - Perù 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
NP - Nepal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
Totale 9.097
Città #
Santa Clara 935
Ashburn 420
Warsaw 405
Fairfield 347
Singapore 313
Chandler 266
Jacksonville 237
Hong Kong 226
Dublin 201
Woodbridge 170
Seattle 169
Cambridge 165
Wilmington 127
Milan 123
San Jose 121
Seoul 118
Houston 117
Beijing 97
Ann Arbor 71
Buffalo 64
Council Bluffs 62
Princeton 56
Los Angeles 54
The Dalles 52
Munich 48
Lauterbourg 47
Rome 46
Ho Chi Minh City 44
Boardman 40
Boston 38
Hanoi 36
Altamura 34
Hefei 34
Lawrence 34
Turku 34
Melbourne 32
Dallas 31
Moscow 31
San Diego 29
Medford 28
Mumbai 26
New York 26
Florence 22
Kent 22
Columbus 21
Shanghai 18
Naples 15
Bologna 14
London 14
São Paulo 14
Norwalk 13
Orem 12
Falls Church 11
Helsinki 10
Paris 10
Verona 10
Abidjan 9
Figino 9
Palermo 9
Tokyo 9
Toronto 9
Bern 8
Chicago 8
Frankfurt Am Main 8
Frankfurt am Main 8
Genoa 8
Haiphong 8
Stockholm 8
Turin 7
Auburn Hills 6
Dong Ket 6
Guangzhou 6
Hillsboro 6
Jakarta 6
Phoenix 6
Redondo Beach 6
Tianjin 6
Abuja 5
Atlanta 5
Bari 5
Biên Hòa 5
Brasília 5
Chennai 5
Da Nang 5
Denver 5
Duncan 5
Laurel 5
Montreal 5
Ribeirão Preto 5
West Jordan 5
Andover 4
Ankara 4
Bishkek 4
Bremen 4
Brooklyn 4
Hải Dương 4
Izmir 4
Johannesburg 4
Pescara 4
Shenzhen 4
Totale 6.021
Nome #
Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. 326
Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility 289
High prevalence in ACE DD and genotype in patients with atrial fibrillation 274
Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy. 227
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. 216
Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation. 214
Management of patients with acute atrial fibrillation in the ED 212
Effects of cryoablation and radiofrequency ablation on endothelial and blood clotting activation 203
Dual-site left ventricular cardiac resynchronization therapy. 201
Are body mass index and age independent risk factors for new-onset atrial fibrillation after cardiac surgery regardless of left atrial size and left ventricular ejection fraction value? 199
Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy. 195
A contribution for validation of ECG criteria for interatrial conduction delay. 192
Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation 190
Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling. 190
Multicenter experience with implantable defibrillators subject to recall. 190
Overweight and aging increase the risk of atrial fibrillation after cardiac surgery independently of left atrial size and left ventricular ejection fraction 188
Simplified Selvester Score: a practical electrocardiographic instrument to predict response to CRT 188
Cardiac Resynchronization Therapy Acutely Improves Ventricular-Arterial Coupling by Reducing the Arterial Load: Assessment by Pressure-Volume Loops. 186
Effects of ischemia and reperfusion on QT dispersion during coronary angioplasty 185
Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function 184
Acute effects of His bundle pacing versus left ventricular and right ventricular pacing on left ventricular function. 181
Left ventricular mass and progenitor cells in chronic heart failure patients 179
Electrophysiologic procedures and activation of the hemostatic system 174
Cardiac effects of clomipramine treatment 172
Which factors predict the behavior of ventricular extrasystoles in athletes over time? 167
ATRIAL FIBRILLATION AND CARDIAC RESYNCHRONIZATION THERAPY: THE MASCOT STUDY. 161
Enhanced cardiac norepinephrine release in patients with idiopathic ventricular tachycardia related to the occurrence of arrhythmias 159
Activation of the coagulation system during electrophysiologic invasive study with and without ablation 159
Activation of hemostatic system during electrophysiological procedures 158
Circadian Pattern of the QT Dispersion Using 3 Orthogonal Leads of an Holter ECG in Patients with Heart Failure. 155
Rational bases for the therapy of supraventricular tachycardias and their management 153
Diagnostic accuracy of extended-length electrocardiogram in differentiating between athlete's heart and hypertrophic cardiomyopathy. 153
Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy 151
Influence of age, lead axis, frequency of arrhythmic episodes, and atrial dimensions on P wave triggered SAECG in patients with lone paroxysmal atrial fibrillation 151
Recurrent patterns of atrial depolarization during atrial fibrillation assessed by recurrence plot quantification 150
Evolution and prognostic significance of diastolic filling pattern in cardiac resynchronization therapy. 148
Altered values of heart rate variability in patients with relapse of atrial fibrillation during the first week after electrical cardioversion: peliminary data 145
Atrioventricular interval optimazation in the right atrial appendage and interatrial septum pacing: a comparison between echo and peak endocardial acceleration measurements 139
Simultaneous assessment of electrocardiographic parameters for risk stratification: validation in healthy subjects 138
Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction. 134
Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy 130
Tricuspid annular plane systolic excursion evaluation improves selection of cardiac resynchronization therapy patients 127
Wavelenght index at three atrial sites in patients with peroxysmal atrial fibrillation 125
Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. 121
XL-ECG in athletee's physiological heart hypertrophy: a time saving procedure 118
Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation 117
Prevention of short term reversible chronic atrial fibrillation by permanent pacing at the triangle of Koch 114
New therapeutic strategies in heart failure. Which patients need defibrillation backup? 112
Microvolt T-wave alternans as predictor of electrophysiological testing results in professional competitive athletes 112
Prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia: role of right atrial linear ablation and pacing site. 106
Non-invasive stratification of patients at high risk from coronary disease 103
Role of natriuretic peptides in heart failure patients with special reference to those on cardiac resynchronization therapy 100
Normal and abnormal atrial activation. An update with special reference to surface electrocardiogram 96
Paroxysmal atrial fibrillation: epidemiology and clinical relevance 96
Natriuretic peptides and cardiac resynchronization therapy 91
How does the hemostatic system respond to electro-physiological procedures? 85
Totale 9.129
Categoria #
all - tutte 24.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022336 0 31 10 20 20 23 11 20 28 12 72 89
2022/2023990 98 150 38 94 70 182 131 60 106 5 35 21
2023/2024322 20 37 55 20 28 42 9 74 1 9 20 7
2024/20252.611 69 251 161 415 813 321 34 143 145 58 112 89
2025/20262.382 309 340 132 126 259 92 294 99 146 175 44 366
2026/2027136 57 79 0 0 0 0 0 0 0 0 0 0
Totale 9.129